Skip to main content
F
Formulate
Jobs
Companies
Drugs
Advisor
NEW
Insider Intel
Salary
Pricing
Toggle theme
Toggle theme
Menu
argenx Jobs | Formulate
Jobs
argenx
argenx Jobs
Belgium - Zwijnaarde
Biotechnology
argenx is a life sciences company focused on Antibody therapies.
124
open positions at argenx
View Full Profile
Filters:
Immunology ×
Nurse Case Manager, West
argenx
Posted 3w ago
Remote
$136K - $187K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
MANAGER
H-1B · 1 FY23
Executive Assistant
argenx
Posted 3w ago
Boston, MA, USA
$76K - $105K
Full-time
Associate Director, US Patient Advocacy
argenx
Posted 3w ago
Remote
$164K - $226K
Full-time
Nurse Case Manager, Central
argenx
Posted 3w ago
Remote
$136K - $187K
Full-time
Associate Director Ethics & Compliance
argenx
Posted 3w ago
Remote
Full-time
Device Project Leader
argenx
Posted 3w ago
Remote
Full-time
CMC Development Lead
argenx
Posted 3w ago
Gent, Belgium
Full-time
Medical Affairs and Evidence Generation Asset Lead – Executive Director
argenx
Posted 3w ago
Remote
$326K - $448K
Full-time
Data Management Lead
argenx
Posted 3w ago
Gent, Belgium; Boston, MA, USA
Full-time
Senior Director, Patient Marketing Excellence Lead
argenx
Posted 3w ago
Boston, MA, USA
Full-time
Rheumatology Territory Business Manager, Saint Louis, MO
argenx
Posted 1mo ago
St Louis; Des Moines; Springfield
Full-time
Rheumatology Territory Business Manager, San Antonio/Valley
argenx
Posted 1mo ago
San Antonio; Austin
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Washington, D.C.
argenx
Posted 1mo ago
Washington D.C; Alexandria
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Houston, TX
argenx
Posted 1mo ago
Houston
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Portland, OR
argenx
Posted 1mo ago
Portland, OR; Boise
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Birmingham, AL
argenx
Posted 1mo ago
Birmingham, AL; Montgomery; Huntsville
$140K - $193K
Full-time
Field Clinical Educator, Mid Atlantic
argenx
Posted 1mo ago
Roanoke; Washington D.C; Charleston
Full-time
Rheumatology Territory Business Manager, Miami, FL
argenx
Posted 1mo ago
Miami
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Pittsburgh, PA
argenx
Posted 1mo ago
Pittsburgh; Erie
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Las Vegas, NV
argenx
Posted 1mo ago
Las Vegas
$140K - $193K
Full-time
Previous
1
2
3
Company Overview
Active Jobs
171
Pipeline Programs
88
Drug Products
2
Clinical Trials
91
View Full Company Profile
Therapeutic Areas
Neurology
Immunology
Oncology
Links
Company Website
Careers Page
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
Executive
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
Executive
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Legal
Immunology
Executive
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Immunology
MID
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
Senior
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Remote
Medical Affairs
Immunology
Executive
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
Senior
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
Executive
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Immunology
MID
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
4
5
6
7
Next
Hematology
Rare Diseases